MediFind
Condition

Junctional Epidermolysis Bullosa

Latest Research

Latest Advance
Study
  • Condition: Junctional Epidermolysis Bullosa (GS-JEB) Patients with Nonsense Mutations
  • Journal: Molecular therapy : the journal of the American Society of Gene Therapy
  • Treatment Used: Gentamicin
  • Number of Patients: 0
  • Published —
This study examined if 0.5% gentamicin topical ointment could create new laminin 332 in generalized severe junctional epidermolysis bullosa (blistering disease; GS-JEB) skin wounds.
Latest Advance
Study
  • Condition: Junctional Epidermolysis Bullosa (JEB)
  • Journal: Expert opinion on biological therapy
  • Treatment Used: Emerging Drug, Cell, and Gene Therapies
  • Number of Patients: 0
  • Published —
This article discusses emerging drug, cell, and gene therapies for junctional epidermolysis bullosa (rare genetic blistering disorder; JEB).